ストックスクリーナーアプリを入手
84.54
1.50%
1.25
プレマーケット:
84.31
-0.23
-0.27%
Apogee Therapeutics Inc (APGE) 最新ニュース
Trading Systems Reacting to (APGE) Volatility - Stock Traders Daily
Insider to sell 22,000 shares at APGE (NASDAQ: APGE) after 11,000 sold - Stock Titan
CFO of Apogee Therapeutics (APGE) sells 2,000 shares under 10b5-1 plan - Stock Titan
Apogee Therapeutics (NASDAQ:APGE) Upgraded to Strong-Buy at Rothschild & Co Redburn - MarketBeat
Jennison Associates LLC Invests $43.68 Million in Apogee Therapeutics Inc. $APGE - MarketBeat
Rothschild & Co initiates coverage of Apogee Therapeutics (APGE) with buy recommendation - MSN
Insider sales reported for APGE (NASDAQ: APGE) — five 2,000-share trades - Stock Titan
Rothschild & Co Redburn Initiates Apogee Therapeutics(APGE.US) With Buy Rating, Announces Target Price $140 - Moomoo
Pictet Asset Management Holding SA Takes $23.62 Million Position in Apogee Therapeutics Inc. $APGE - MarketBeat
Rothschild Redburn initiates Apogee stock with buy on AD therapy - Investing.com UK
Rothschild Redburn initiates Apogee stock with buy on AD therapy By Investing.com - Investing.com India
Apogee Therapeutics rises on positive phase 2 data for Zumilokibart in atopic dermatitis - MSN
APGE stock up as skin disease drug shows sustained 52-week efficacy - MSN
Apogee Therapeutics (APGE) Study result Summary - Quartr
Apogee Therapeutics (APGE) Guggenheim Securities Emerging Outlook: Biotech Summit 2026 summary - Quartr
Apogee Therapeutics Stock Surges as Investors Bet on Immunology Breakthrough - HarianBasis.co
Apogee Therapeutics Inc. (APGE): Primary Challenger to Established Blockbusters - Yahoo Finance
Apogee Therapeutics prices upsized $350M offering at $70 a share - MSN
How Apogee Therapeutics Inc. (APGE) Affects Rotational Strategy Timing - Stock Traders Daily
Apogee Therapeutics, Inc. ($APGE) CEO 2025 Pay Revealed - Quiver Quantitative
Apogee Therapeutics Announces Upcoming Board Resignations, Governance Shift - TipRanks
Apogee Therapeutics (APGE) 2026 meeting to vote on directors, pay and auditor - Stock Titan
Two directors resign from Apogee Therapeutics (NASDAQ: APGE) board, shrinking it to seven - Stock Titan
Certain Common Stock of Apogee Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-APR-2026. - marketscreener.com
Certain Pre-Funded Warrants of Apogee Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-APR-2026. - marketscreener.com
Certain Restricted Stock Units of Apogee Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-APR-2026. - marketscreener.com
Certain Stock Options of Apogee Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-APR-2026. - marketscreener.com
Apogee Thera (APGE) Stock Price Target | Q4 2025: Earnings Beat EstimatesTrending Volume Leaders - Cổng thông tin điện tử Tỉnh Sơn La
APGE (Apogee Therapeutics Inc.) posts narrower Q4 2025 loss than estimates, shares rise modestly after its latest quarterly earnings release.GDR - Cổng thông tin điện tử tỉnh Tây Ninh
APGE (Apogee Therapeutics Inc.) Q4 2025 EPS outpaces forecasts, shares gain as investors reward narrower than expected loss.Social Flow Trades - UBND thành phố Hải Phòng
APGE Earnings History & Surprises | EPS & Revenue Results | APOGEE THERAPEUTICS INC (NASDAQ:APGE) - ChartMill
Apogee Therapeutics (APGE) CEO exercises options, holds 1.14M shares - Stock Titan
Apogee Therapeutics stock hits all-time high at 92.48 USD By Investing.com - Investing.com India
Insider Sell: Jane Henderson Sells 2,000 Shares of Apogee Therap - GuruFocus
Apogee Therapeutics CFO Henderson sells $180,000 in stock - Investing.com
Apogee Therapeutics CFO Henderson sells $180,000 in stock By Investing.com - Investing.com India
Apogee Therapeutics (APGE) CFO sells 2,000 shares under 10b5-1 plan - Stock Titan
Apogee Therapeutics stock hits all-time high at 92.48 USD - Investing.com
1.77%
0.25%
大文字化:
|
ボリューム (24 時間):